6th Annual Advisory Board and Speaker Bureau Management Conference

　　The implementation of the Physician Payments Sunshine Act has increased regulatory scrutiny for both advisory boards and speaker programs; challenging pharmaceutical companies to report and publish every physician interaction worth $10 or more.  With the first report due to go out in March, companies and physicians are left struggling with the implications of a public relationship.As speaker programs and advisory boards are very important to life science companies, it is important to discuss and solve some of the additional challenges facing the industry; including the structuring global advisory boards, enhancing industry participation while reporting, and creating a positive relationship with academic institutions and health systems.

 

　　The 6th Advisory Board and Speaker Bureau Management Conference is designed to address these challenges while assisting pharmaceutical, biotechnology, and medical device companies explore the best practices and opportunities to advance drug development and maintain a balance with compliance and business objectives.

 

　　This ExL event provides opportunities for Key Opinion Leaders and Life Science Innovators to work together as the industry moves forward into a new era, the Post-Sunshine Act era.

 

　　TOP FIVE REASONS TO ATTEND

 

　　Explore ways to cross-train advisory board and speaker program management on changing regulations and industry trends.Remain up to date on regulatory requirements and transparent reporting from both a domestic standpoint and internationally.Optimize advisory boards and speaker programs by learning techniques to re-engage physician participation, develop dynamic messages, and enhance participant selection.Take advantage of technological advances in the industry to push your company ahead of the competition.Capitalize on networking opportunities and lessons learned from your peers in multiple case studies and panels.